Hemab Therapeutics Holdings, Inc.COAG
Price (close)
$34.74
Market cap
$1.6B
P/E
—
Revenue (FY)
—
Net income
—
Dividend yield
—
1-year total return
—
Net margin
—
Revenue growth
—
Debt / equity
—
What Hemab Therapeutics Holdings, Inc. does.
No business description on file yet.
Revenue and profit, by fiscal year.
| Fiscal year | 2024 | 2025 |
|---|
More on COAG.
- Hemab Therapeutics Holdings, Inc. summary
- Hemab Therapeutics Holdings, Inc. financial statements
- Hemab Therapeutics Holdings, Inc. key metrics
- Hemab Therapeutics Holdings, Inc. health scores and style box
- Hemab Therapeutics Holdings, Inc. earnings
- Hemab Therapeutics Holdings, Inc. dividends
- Hemab Therapeutics Holdings, Inc. valuation
- Hemab Therapeutics Holdings, Inc. ownership and insiders
- Hemab Therapeutics Holdings, Inc. peers
Figures from Hemab Therapeutics Holdings, Inc.'s filings with the U.S. SEC, standardised automatically; prices are end-of-day closes. Not financial advice.